Stroke Mechanisms in Symptomatic Intracranial Atherosclerotic Disease: Classification and Clinical Implications

Xueyan Feng1, Ka Lung Chan1, Linfang Lan1,2

  • 1From the Department of Medicine and Therapeutics (X.F., K.L.C., L.L., Y.S., X.L., T.W.L.), the Chinese University of Hong Kong, Prince of Wales Hospital.

Stroke
|August 15, 2019
PubMed

Insights

Identifying stroke mechanisms in intracranial atherosclerotic stenosis is key for prevention. Mixed artery-to-artery embolism and hypoperfusion mechanisms increase stroke relapse risk.

Area of Science:

  • Neurology
  • Vascular Neurology
  • Stroke Medicine

Background:

  • Symptomatic intracranial atherosclerotic stenosis (ICAS) poses a risk for recurrent ischemic events.
  • Understanding the precise stroke mechanism in ICAS is crucial for effective secondary prevention strategies.
  • Current classification of stroke mechanisms in ICAS may lack reproducibility.

Purpose of the Study:

  • To develop and validate reproducible classification criteria for stroke mechanisms in patients with symptomatic ICAS using routine neuroimaging.
  • To explore the clinical implications and prognostic value of these classified stroke mechanisms.

Main Methods:

  • A cohort of 153 patients with acute ischemic stroke due to 50%-99% stenosis in the anterior circulation ICAS was recruited.
  • Two independent investigators classified stroke mechanisms (parent artery atherosclerosis, artery-to-artery embolism, hypoperfusion, mixed) based on infarct topography and angiography.
  • Reproducibility of the classification criteria was assessed using intraclass correlation coefficients (κ).

Main Results:

  • The most frequent mechanisms were isolated hypoperfusion (35.3%) and mixed artery-to-artery embolism and hypoperfusion (37.3%).
  • The mixed mechanism group showed higher rates of dyslipidemia and hypertension.
  • The proposed classification criteria demonstrated substantial to excellent intrarater and interrater reproducibility (κ = 0.791–0.908).
  • A mixed mechanism of artery-to-artery embolism and hypoperfusion was associated with a significantly higher risk of recurrent ischemic stroke within 1 year (24.4% vs. 7.8%).

Conclusions:

  • Artery-to-artery embolism and hypoperfusion frequently coexist in ICAS-related ischemic stroke.
  • These combined mechanisms are associated with an increased risk of stroke recurrence.
  • The developed classification criteria are reproducible and aid in stratifying stroke risk in ICAS patients.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
572
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
717
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
332
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
508
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
366
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
546